Incremental Risk of Adverse Events with Oral Janus Kinase Inhibitor Use in Atopic Dermatitis and Other Indications: A Systematic Review and Meta-Analysis. (2024). SKIN The Journal of Cutaneous Medicine, 8(1), s320. https://doi.org/10.25251/skin.8.supp.320